Avid Bioservices Inc (CDMO)

[entdoc]

The previously cited new article on colorectal cancer refractory to/or resistant to, irradiation therapy is killed completely in a high percentage (of bald mice) by adding an anti-PE-like activating compound to the irradiation protocol. So "fossfatwiddleEthanolamean"..."-PE" is another important membrane compound in cancers...in ADDITION to "-PS" hosphatidylserine,the membrane compound Bavituximab homes in on. This means another phospholipid is a huge player intesting a cancer...colon cancer. Preclinical tests of a compound which blocks -PE "clogging" makes tumors enormously mores responsive...makes them dead tumors. So, manipulate membrane PE exposure as well as PS, with Bavi. If you saw this science article and wanted to know what drug company has patents on -PE treatment applications, you would probably find the PPHM patent library large in that space. Interesting stuff.